LINEAGE CELL THERAPEUTICS IN's ticker is and the CUSIP is 53566P909. A total of 3 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 24,100 | $28,438 | 0.00% |
| SIMPLEX TRADING, LLC | 200 | $0 | 0.00% |
This page lists LINEAGE CELL THERAPEUTICS IN's shareholders in Q3 2023. To view LINEAGE CELL THERAPEUTICS IN's shareholder history, click here.